Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Haseeb Jafri"'
Autor:
Haseeb Jafri, MD, Alan Cheng, MD, FHRS
Publikováno v:
HeartRhythm Case Reports, Vol 1, Iss 4, Pp 198-200 (2015)
Externí odkaz:
https://doaj.org/article/5f8ef79d1f454158b3d03538d2c9d781
Autor:
Hugh Calkins, Haseeb Jafri
Publikováno v:
Interventional Cardiology. 7:329-332
The Heart Rhythm Society Scientific Sessions 2015 was held in Boston (MA, USA) from the 13th to the 16th of May 2013. More than 11,000 attendees from more than 50 countries gathered in Boston. This report focuses on the novel clinical trials presente
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a9fc1c69b6db0a82d424135d7ea9bec
https://doi.org/10.2217/ica.15.27
https://doi.org/10.2217/ica.15.27
Autor:
Alan Cheng, Haseeb Jafri
Publikováno v:
HeartRhythm Case Reports, Vol 1, Iss 4, Pp 198-200 (2015)
HeartRhythm Case Reports
HeartRhythm Case Reports
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcc8b7a2432041300b08017b33fdbbed
Autor:
Vasileia Varvarigou, Mei Chung, Georgios D Kitsios, Radley C. Sheldrick, Haseeb Jafri, Jessica K. Paulus, Issa J Dahabreh, Thomas A Trikalinos, Jeremy A. Rassen
Publikováno v:
European Heart Journal. 33:1893-1901
Aims Randomized controlled trials (RCTs) are the gold standard for assessing the efficacy of therapeutic interventions because randomization protects from biases inherent in observational studies. Propensity score (PS) methods, proposed as a potentia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db356a66b908533cba61bdc2e9e4db5f
https://doi.org/10.1093/eurheartj/ehs114
https://doi.org/10.1093/eurheartj/ehs114
Publikováno v:
Ibnosina Journal of Medicine and Biomedical Sciences. :135-138
Angioedema has been associated with a several causes that which includes acquired C1 esterase deficiency, hereditary angioedema (HAE), idiopathic, and pharmacological. It is a rare side effect of angiotensin converting enzyme (ACE) inhibitors that us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7674492ecb4cb6a52b9cf28b4b03fd54
https://doi.org/10.4103/1947-489x.210884
https://doi.org/10.4103/1947-489x.210884
Publikováno v:
Clinical Lipidology. 4:565-571
Niacin has long been used as an effective lipid-altering therapy, particularly for raising HDL-C and lowering triglyceride levels. In addition, niacin modestly lowers LDL-C levels. LDL-C circulates in the blood as a heterogeneous population of variou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09d59ab1416d79717d85c5a7ec2a18db
https://doi.org/10.2217/clp.09.44
https://doi.org/10.2217/clp.09.44
Autor:
Alawi A. Alsheikh-Ali, Jeffrey T. Kuvin, Paula Mooney, Richard H. Karas, Haseeb Jafri, Carey Kimmelstiel
Publikováno v:
Journal of Clinical Lipidology. 3:45-50
The importance of the number of circulating low-density lipoprotein (LDL) cholesterol particles, in addition to total LDL level, has been increasingly recognized. The effects of extended-release niacin (ERN) on LDL particle numbers have not been stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c29d200d776ee996894da6201fac3935
https://doi.org/10.1016/j.jacl.2008.12.003
https://doi.org/10.1016/j.jacl.2008.12.003
Publikováno v:
Annals of internal medicine. 153(12)
Low levels of high-density lipoprotein cholesterol (HDL-C) are associated with an increased risk for myocardial infarction (MI). Although statins reduce the risk for MI, most cardiovascular events still occur despite statin treatment.Using meta-analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0f4434afb62cc18829594138a01a903
https://pubmed.ncbi.nlm.nih.gov/21173414
https://pubmed.ncbi.nlm.nih.gov/21173414
Background Coronary artery disease (CAD) risk is not fully revealed by traditional risk factors. Identification of a simple, noninvasive tool that allows for detection of high-risk CAD patients and can be applied in large populations and clinical set
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::181bb9fdcdad4a7cd8e37d2268e1b585
https://europepmc.org/articles/PMC2914463/
https://europepmc.org/articles/PMC2914463/
Autor:
Haseeb Jafri, Jeffrey T Kuvin, Alawi A Alsheikh-Ali, Paula Mooney, Carey D Kimmelstiel, Richard H Karas
Publikováno v:
Circulation. 118
Introduction: The importance of the number of circulating low-density lipoprotein cholesterol (LDL-C) particles, in addition to the total level of LDL-C is increasingly recognized. The effects of Extended Release Niacin (ERN) on LDL-C particle number
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64ef60ec72d2d1148ec3b21f35bcf666
https://doi.org/10.1161/circ.118.suppl_18.s_1150-c
https://doi.org/10.1161/circ.118.suppl_18.s_1150-c